av/china-sxt-pharmaceuticals--big.svg

NASDAQ:SXTC

China SXT Pharmaceuticals, Inc.

  • Stock

USD

Last Close

0.48

08/11 21:00

Market Cap

778.80K

Beta: 0.73

Volume Today

112.48K

Avg: 502.62K

PE Ratio

−0.31

PFCF: 87.82

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
1.19M
-
1.19M
0.21%
1.54M
29.61%
-10.29M
768.38%
-2.75M
73.29%
-5.74M
108.72%
-5.93M
3.46%
-3.10M
47.79%
depreciation and amortization
99.23K
-
129.44K
30.45%
180.92K
39.77%
331.84K
83.42%
345.41K
4.09%
320.01K
7.36%
250.16K
21.83%
203.25K
18.75%
deferred income tax
-5.85K
-
-7.72K
31.99%
-101.72K
1,217.13%
-192.68K
89.42%
328.15K
270.30%
3.23M
882.82%
stock based compensation
2
-
11
450%
5.69M
51,736,590.91%
1.27M
77.70%
2.33M
83.90%
554.57K
76.24%
352.10K
36.51%
change in working capital
-991.33K
-
608.99K
161.43%
-1.54M
352.90%
1.95M
226.39%
-1.61M
182.52%
1.90M
218.48%
1.42M
25.62%
-381.56K
126.96%
accounts receivables
-942.97K
-
384.43K
140.77%
-1.81M
571.10%
104.00K
105.74%
-519.24K
599.27%
831.47K
260.13%
912.95K
9.80%
-321.42K
135.21%
inventory
384.22K
-
-274.38K
171.41%
177.64K
164.74%
39.71K
77.65%
38.62K
2.74%
-180.80K
568.14%
408.95K
326.19%
-190.29K
146.53%
accounts payables
-1.47M
-
966.57K
165.65%
-567.31K
158.69%
302.27K
153.28%
-619.54K
304.96%
-22.79K
96.32%
9.70K
142.56%
-29.25K
401.59%
other working capital
1.04M
-
-467.63K
144.98%
660.63K
241.27%
1.50M
127.15%
-506.08K
133.73%
1.28M
351.97%
83.91K
93.42%
159.41K
89.97%
other non cash items
-2
-
66.89K
3,344,450%
3.35M
4,915.04%
1.62M
51.83%
1.12M
30.76%
408.69K
63.47%
2.30M
461.86%
net cash provided by operating activities
293.04K
-
1.92M
555.25%
239.19K
87.54%
934.25K
290.58%
-1.32M
240.92%
268.29K
120.38%
-80.76K
130.10%
-1.93M
2,287.47%
investments in property plant and equipment
-186.31K
-
-1.05M
463.97%
-610.09K
41.94%
-406.66K
33.34%
-93.04K
77.12%
-62.49K
32.84%
-70.68K
13.11%
-7.06K
90.01%
acquisitions net
purchases of investments
-3.59M
-
-8.85M
146.38%
sales maturities of investments
other investing activites
-92.42K
-
-1.50M
-
3.13M
308.84%
15.58K
99.50%
58.38K
274.69%
33.49K
42.64%
net cash used for investing activites
-186.31K
-
-1.14M
513.58%
-610.09K
46.63%
-5.50M
800.97%
-5.81M
5.62%
-46.91K
99.19%
-12.30K
73.77%
26.42K
314.77%
debt repayment
-50.56K
-
-314.22K
521.47%
-2.38M
658.35%
-1.20M
49.81%
-124.95K
89.55%
-33.05K
73.54%
-26.11K
21.02%
-1.31M
4,911.26%
common stock issued
6.49M
-
3.12M
-
2.19M
29.54%
common stock repurchased
6.49M
-
dividends paid
-2.38M
-
other financing activites
826.84K
-
4.22M
410.43%
12.53M
196.99%
-1.49M
111.86%
772.88K
151.98%
-3.93M
608.83%
net cash used provided by financing activities
-50.56K
-
-314.22K
521.47%
9.04M
2,977.66%
3.02M
66.55%
12.41M
310.32%
1.60M
87.15%
2.94M
84.41%
-2.62M
189.22%
effect of forex changes on cash
-2.04K
-
31.88K
1,660.55%
-37.02K
216.13%
-466.81K
1,160.84%
784.54K
268.06%
394.12K
49.76%
-1.05M
366.34%
-765.23K
27.10%
net change in cash
54.13K
-
494.68K
813.86%
8.63M
1,645.40%
-2.00M
123.22%
6.07M
402.86%
2.21M
63.59%
1.80M
18.63%
-5.29M
394.15%
cash at beginning of period
11.44K
-
65.57K
473.21%
657.77K
903.15%
9.29M
1,312.65%
7.29M
21.58%
13.36M
83.33%
15.57M
16.55%
17.37M
11.55%
cash at end of period
65.57K
-
560.25K
754.43%
9.29M
1,558.53%
7.29M
21.58%
13.36M
83.33%
15.57M
16.55%
17.37M
11.55%
12.08M
30.46%
operating cash flow
293.04K
-
1.92M
555.25%
239.19K
87.54%
934.25K
290.58%
-1.32M
240.92%
268.29K
120.38%
-80.76K
130.10%
-1.93M
2,287.47%
capital expenditure
-186.31K
-
-1.05M
463.97%
-610.09K
41.94%
-406.66K
33.34%
-93.04K
77.12%
-62.49K
32.84%
-70.68K
13.11%
-7.06K
90.01%
free cash flow
106.73K
-
869.44K
714.58%
-370.89K
142.66%
527.59K
242.25%
-1.41M
367.18%
205.80K
114.60%
-151.44K
173.59%
-1.94M
1,177.80%

All numbers in USD (except ratios and percentages)